乳腺癌患者全身炎症反应指数（SIRI）的预后和临床病理学价值：一项荟萃分析

IF 4.9 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Annals of medicine Pub Date : 2024-04-03 DOI:10.1080/07853890.2024.2337729

Sunhuan Zhang, Tongtong Cheng

引用次数: 0

摘要

许多研究探讨了全身炎症反应指数（SIRI）在预测乳腺癌（BC）患者预后方面的价值；然而，这些研究结果仍存在争议。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Prognostic and clinicopathological value of systemic inflammation response index (SIRI) in patients with breast cancer: a meta-analysis

Many studies have explored the value of the systemic inflammation response index (SIRI) in predicting the prognosis of patients with breast cancer (BC); however, their findings remain controversial...

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Annals of medicine 医学-医学：内科

CiteScore

4.90

自引率

0.00%

发文量

292

审稿时长

3 months

期刊介绍： Annals of Medicine is one of the world’s leading general medical review journals, boasting an impact factor of 5.435. It presents high-quality topical review articles, commissioned by the Editors and Editorial Committee, as well as original articles. The journal provides the current opinion on recent developments across the major medical specialties, with a particular focus on internal medicine. The peer-reviewed content of the journal keeps readers updated on the latest advances in the understanding of the pathogenesis of diseases, and in how molecular medicine and genetics can be applied in daily clinical practice.